ROBERT PETIT
CIK 1576077 · See Remarks · last filed 2026-02-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$340.0K
Companies
4
Total Filings
63
Lifetime Open-Market Net
-$208.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OSTX | See Remarks | 200,000 | $1.70 | $340.0K | $0 | 2 | 2026-02-13 |
| Ayala Pharmaceuticals, Inc. (ADXS) Delisted | Chief Scientific Officer | 231,206 | $0.60 | $139.6K | -$7.1K | 2 | 2018-11-07 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Chief Scientific Officer | 243,660 | — | — | -$99.6K | 25 | 2018-08-01 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Chief Scientific Officer | 123,378 | — | — | -$102.0K | 34 | 2016-10-04 |
Recent Filings · Page 3 of 7
63 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-06-01 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +265 | $2.1K | EDGAR |
| 2017-05-01 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +58,131 | $2.1K | EDGAR |
| 2017-04-03 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | −2,235 | -$18.4K | EDGAR |
| 2017-03-01 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | +246 | $2.2K | EDGAR |
| 2017-02-02 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | +234 | $2.1K | EDGAR |
| 2017-01-03 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | +383 | $2.7K | EDGAR |
| 2016-12-01 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | +225 | $1.9K | EDGAR |
| 2016-11-07 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-02 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | −2,634 | -$22.0K | EDGAR |
| 2016-10-04 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +181 | $1.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.